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LONG TERM FOLLOW-UP IN A PATIENT WITH
PAPILLARY GLIONEURONAL TUMOR
Guilherme Borges1, Leonardo Bonilha1,
Ana Silvia Menezes2, Luciano de Souza Queiroz2, 
Edmur Franco Carelli1, Veronica Zanardi3, Jose Ribeiro Menezes3
ABSTRACT - We report a case of a young female patient with a rare and recently described form of brain
tumor. This patient had a history of headache, hemiparesis and motor simple partial seizures. Her investi-
gation revealed a brain tumor involving the left frontal and parietal lobes. The radiological images showed
a cystic mass with multiple nodular masses and a rim of contrast enhancement extending from the right
parietal cortex to the ipsilateral ventricle and corpus callosum. The patient underwent gross resection of
the lesion and the histological analysis of the surgical specimen revealed a pseudopapillary structure
formed by delicate vessels intermixed with a fibrillary pattern and bordered by intense astrocytic reaction
with Rosenthal fibers. These features correspond to the recently described mixed neuronal-glial neoplasm,
the papillary glioneuronal tumor. The patient has been followed for five years since the surgical treatment,
without evidence of tumor recurrence, confirming the indolent behavior of this type of tumor. 
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Seguimento tardio de paciente com tumor papilar glioneuronal
RESUMO - Relatamos o caso de uma jovem paciente com um tumor cerebral raro e recentemente descrito.
Essa paciente apresentou-se com queixas de cefaléia, hemiparesia e crises epiléticas parciais simples. Sua
investigação revelou um tumor cerebral envolvendo os lobos frontal e parietal esquerdos. As imagens radio-
lógicas mostraram uma massa cística com massas nodulares múltiplas e reforço anelar de contraste esten-
dendo do córtex parietal direito aos ventrículo lateral e corpo caloso ipsilaterais. A paciente se submeteu
à ressecção do tumor e a análise histológica da lesão revelou uma estrutura pseudopapilar formada por
vasos delicados entremeados com um padrão fibrilar e emoldurada por intensa reação astrocítica com fibras
de Rosenthal. Essas características correspondem a uma forma de neoplasia mista glial-neuronal recente-
mente descrita, o tumor papilar glioneuronal. A paciente está em seguimento desde a cirurgia sem evidên-
cia de recorrência tumoral, confirmando o comportamento benigno desse tipo de tumor
PALAVRAS-CHAVE: tumor papilar glioneuronal, tumor misto glioneuronal, tumor cerebral, glioma.
Mixed glioneuronal tumors form a heteroge-
neous group. A great number of histological forms
have been described and the WHO classification
includes among neuronal and mixed neuronal-
glial neoplasm the following tumors: gangliocy-
toma, dysembryoplastic neuroepithelial tumor
(DNT), ganglioglioma, anaplastic ganglioglioma
and central neurocytoma1. In 1998, a new variant
of mixed glioneuronal tumor was described. Komori
et al. reported 9 cases of an extraventricular tumor
of indolent behavior composed primarily of glio-
neuronal elements with prominent pseudopapil-
lary structures2. Somewhat distinct from other vari-
ants previously described, this unusual mixed glio-
neuronal tumor of the central nervous system was
called papillary glioneuronal tumor (PGNT). The
new entity was characterized by two distinct mor-
phologic components: 1) a compact pseudopapil-
lae composed of hyalinized vessels covered by a sin-
gle layer of glial fibrillary acid protein (GFAP)-pos-
itive astrocytes; and 2) synaptophysin-positive neu-
ronal cells of varying size, like neurocytes, ganglioid
cells and ganglion cells within neuropil2. The first
report of this new pathological entity was published
in 1998, comprising nine very similar cases of peri-
ventricular cystic intracranial lesions2 and after that,
other two cases have been described3,4.
In this present article we present a case of a 14
year-old patient with a cystic extraventricular neo-
plasm who was submitted to surgical treatment.
Analysis of the pathological specimen excised was
consistent with the diagnosis of PGNT. Our case
report was approved by the Ethical Committee of
our Medical School.
CASE
Clinical presentation - A fourteen year-old female
patient was admitted for medical evaluation in Septem-
ber, 1997 due to an 18 month history of headache asso-
ciated with a mild decrease in muscle strength in her left
arm and leg. Focal brief motor seizures involving her left
arm were present in the time of the onset of the hemi-
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paresis were totally controlled with antiepileptic drugs.
During her physical examination she was found to be
awake and alert and only a mild left side hemiparesis
was noticeable. She underwent further investigation
and a magnetic resonance imaging (MRI) (Fig 1) showed
a large cystic lesion in the left frontal and parietal lobes
extending from the parietal subcortical area to the ipsi-
lateral ventricle and corpus callosum. The tumor had
approximately 5.5 cubic centimeters and was surround-
ed by a thin wall, with delicate intra-cystic trabeculae.
There was intense paramagnetic contrast enhancement
of the tumor wall. The tumor also exerted mass-effect
displacing the thalamus downward.
The patient underwent gross total resection of the
tumor. Frozen-section analysis was inconclusive, and
there was suspicious of pylocitic astrocitoma or ependy-
moma.
Eight days after the surgery the patient was dischar-
ged home, without additional neurological deficits. She
has been followed ever since in our outpatient clinic, with
a mild left side weakness. Two MRI and a CT scan per-
formed up to 56 months after the surgical treatment did
not show signs of tumor recurrence.
Histological analysis - A specimen of subcortical brain
parenchyma infiltrated by a mildly cellular neoplasia
was analyzed. It presented a pseudopapillary structure
formed by delicate small vessels, some of them with a
hyaline wall surrounded by a single layer of uniform, cu-
boid, small cells with oval-shaped nuclei with finely
granular chromatin and scanty cytoplasm. The pseudo-
papillae were intermixed with a fibrillary background
and rare polygonal large cells with abundant cytoplasm
Fig 1. A) T1-weighted MRI axial image without contrast show-
ing a large left cystic parietal lesion. B) T1-weighted MRI axi-
al image showing rim contrast enhancement.
Fig 2. A) Histological section of the surgical specimen showing the pseudo-papillary pattern of the PGNT. B) Histological section of
the surgical specimen showing large cells with abundant cytoplasm. This corresponds to the neural element of the neoplasm. C)
Histological section of the surgical specimen showing reaction gliosis with Rosenthal fibers.
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layer of small cubical cells producing a distinct pseu-
dopapillary aspect. These cells, the so-called pseudo-
papillary component, were regular in size and shape,
had eosinophilic cytoplasm and round nuclei. They
were strongly immunoreactive for GFAP and S-100
protein. Stains for synaptophysin, class III beta-tubu-
lin, NSE and NFP were negative. Hyalines vessels may
be seen in some others glioneuronal tumors5-8. Ho-
wever it is the architectural arrangement the most
distinctive feature associated with the dual glial-neu-
ronal component.
The neuronal element is composed by large,
small or intermediate cells intermixed in a fibril-
lary matrix. Large ganglionic cells presented with
prominent central nucleolus, large cytoplasm with
well developed silver stain and argyrophilic process
on Bielschowsky silver stain. Small neurocytic cells
had small cytoplasm, dark nuclei and none argy-
rophilic process. Intermediate ganglionic cells pos-
sessed intermediate amount of cytoplasm and small-
er nuclei. Intermixed in loose or compact manner,
the “neuronal component” can be associated with
a geometric capillary network resembling an oligo-
dendroglioma3. In fact, according to the most pro-
minent neuronal cell lineage present, the PGNT
bears resemblance with the neuronal tumor in
which each of the neuronal cells is more frequent,
ranging in appearance from neurocytomas to gan-
gliocytoma. The broad spectrum of PGNT neuro-
nal differentiation is unique because it involves
three different stages of neuronal cell matura-
tion. These features are observed in immunophe-
notype studies which demonstrate staining for
class III beta-tubulin, synaptophysin and neurofil-
ament protein9-12.  
The advanced maturation of cellular compo-
nents of PGNT is in concordance with its indolent
behavior. Moreover, the PGNT shares good prog-
nostic features with other neuronal or mixed neu-
roglial tumors such as DNT, neurocytoma and gan-
gliocytoma. This can be observed by the much old-
er age of onset of these tumors when compared
to non-differentiated malignant neoplasms such
as PNET or central neuroblastoma13,14. 
The periventricular location of the majority of
cases of PGNT suggests its possible origin from the
germinative zone in the subependymal plate2. The
presence of identical nuclei and dense bodies in
all cell subtypes within the tumor3 are also indica-
tive of a possible common neuroglial progenitor
cell. In adult mammals, ependymal cells are derived
and prominent nucleolus. In the borders of the lesion
there was intense astrocytic proliferation with conspic-
uous Rosenthal fibers (Fig 2). The cells that delineated
the pseudo-rosettes were immunoreactive with anti-
glial fibrillary acidic protein and vimentin.  The small pop-
ulation of large cells reacted to anti-neuron-specific
anti-synaptophysin and TUJ1 (class III beta-tubulin) anti-
bodies. The cytoarchitecture and immune analysis obser-
ved corresponds to the pathological entity described in
1998 defined as called papillary glioneuronal tumor
(PGNT).
DISCUSSION
The papillary glioneuronal tumor is a low grade
neoplasm distinct from previously described vari-
ants of mixed glioneuronal tumors because of the
evident pseudopapillary architecture and the uni-
que clinical and radiographic features. It was first
described in 1998 in a report of nine very similar
cases of periventricular cystic intracranial masses2.
Two other reports have followed the original des-
cription and overall 11 cases of PGNT have been
described3,4.
The papillary glioneuronal tumor involves white
and gray matter and shows both astrocytic and exten-
sive neuronal differentiation, including neurocytes,
ganglioid and ganglion cells1. All but one case des-
cribed2-4 affected young adults and clinical behavior
is probably indolent, as supposed by the extent of
mature cells and by one report of long follow-up3.
The preferential location involves the cortical
and subcortical portions of the temporal lobe, fol-
lowed by the frontal, parietal and the occipital lo-
bes. Radiological images have showed large peri-
ventricular neoplasms marked by a peripheral ho-
mogeneous or heterogeneous rim of contrast en-
hancement. Overall the lesions were round or
ovoid in shape and the majority had a large cystic
component.  Peri-lesional edema was either mild
or absent. The tumors had an average of approx-
imately 4 to 5 cm and were highly vascularizated.
The solid components in magnetic resonance stud-
ies were isointense in T1-weighted images and iso
to hyperintense in T2-weighted images. Calcifi-
cation was detected in 4 cases.
The histological analysis reveals distinct neuro-
nal and glial conspicuous histological populations.
Glial elements were astrocytes, whereas neuronal
cells were neurocytes, ganglioid or ganglion cells,
showing a spectrum of maturation. A very promi-
nent feature was the presence of highly hyalinized
vessels unsheathed by a single or pseudostratified
from neural stem cells15,16 which can generate the
major types of CNS mature cells: neurons, astro-
cytes and oligodendrocytes17. Neoplastic transfor-
mation of these cells may account for the forma-
tion of glioneuronal tumors, such as the PGNT. 
Finally we provide additional evidence for the
peculiar histological and neuroimaging patterns of
the PGNT. We further highlight the indolent behav-
ior and the benign course of the PGNT. 
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